Study to Compare 2 Doses of Polycap Versus Single Dose of Polycap With or Without Pottasium (TIPSK)
This is a randomized double blind 2x2 factorial controlled trial to evaluate efficacy tolerability of low strength Polycap versus two doses of low strength Polycap in patients with stable cardiovascular disease in reducing blood pressure and LDL.
To evaluate the tolerability and safety of low dose potassium supplementation compared to placebo in patients with stable cardiovascular disease.
Approximately 500 patients are planned to be randomized.
|Ischemic Heart Disease Ischemic Stroke Peripheral Vascular Disease Type 2 Diabetes Mellitus||Drug: Single Dose Polycap Drug: Double dose Polycap|
|Study Design:||Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Participant, Care Provider, Investigator)
Primary Purpose: Treatment
|Official Title:||A RCT With Factorial Design to Compare Safety and Efficacy of 2 Capsules of the Indian Polycap Versus a Single Capsule Along With or Without Oral Potassium Among Patients With Stable Cardiovascular Disease|
- BLOOD PRESSURE LIPIDS [ Time Frame: 8 weeks ]Amongst patients with cardiovascular disease or type 2 diabetes, the study aims to test the safety and efficacy of giving double dose of polycap versus a single dose of polycap for 8 weeks; efficacy to lower blood pressure and elevated lipids and safety assessed as difference with tolerance to double dose of polycap compared to a single dose.
- Tolerability of a Double Dose of Half Strength Polycap [ Time Frame: 8 weeks ]
- Blood Pressure Reduction and Lipid Lowering in Type 2 Diabetics [ Time Frame: 8 weeks ]
|Study Start Date:||April 2010|
|Study Completion Date:||February 2011|
|Primary Completion Date:||February 2011 (Final data collection date for primary outcome measure)|
Active Comparator: SD Polycap without potassium
Single dose polycap without pottasium
Drug: Single Dose Polycap
Low strength polycap contains Ace inhibitor; betablocker; thiazide diuretic; statin; aspirin
Other Name: Polycap
Experimental: DD Polycap plus potassium
Double Dose polycap with potassium
Drug: Double dose Polycap
2 Capsules of low strength polycap with 30mEq of Potassium
Other Name: Full dose polycap
Please refer to this study by its ClinicalTrials.gov identifier: NCT01404078
|Principal Investigator:||Dr.Prem - Pais, MD||St.Johns Research Institute|